CMS: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

Federal Register

Jun 16, 2026

Notice of proposed rule from the Centers for Medicare & Medicaid Services (CMS) that would codify the Medicare Drug Price Negotiation Program, establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022, and propose a modification to the fixed combination drug policy. Comments are due by August 17, 2026.

Healthcare business and finance · Legislation and regulations · Pharmacy and prescription drugs